We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+13.29%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$47.2B
AUM Growth
+$8.08B
(+21%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
35.89%
Holding
5,834
New
1,032
Increased
1,743
Reduced
1,554
Closed
961
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$376M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$115M |
| 3 |
Lam Research
LRCX
|
+$51.4M |
| 4 |
Crown Castle
CCI
|
+$45.4M |
| 5 |
Wyndham Hotels & Resorts
WH
|
+$43.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$59.4M |
| 2 |
VMW
VMware, Inc
VMW
|
+$57.2M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$52.6M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$48M |
| 5 |
Microsoft
MSFT
|
+$43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.27% |
| 2 | Financials | 2.09% |
| 3 | Healthcare | 1.72% |
| 4 | Consumer Discretionary | 1.48% |
| 5 | Industrials | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
3576
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $208K | ﹤0.01% |
23,700
+18,600
| +365% | +$152K |
|
3577
First Bancorp
FBP
$4.42B
| $208K | ﹤0.01% |
12,619
-1,058
| -8% | -$15.6K |
|
3578
Planet Labs
PL
$7.3B
| $207K | ﹤0.01% |
+83,921
| New | +$199K |
|
3579
PUT
Worthington Enterprises
WOR
$2.75B
| $207K | ﹤0.01% |
3,600
-1,915
| -35% | -$84.1K |
|
3580
PUT
Honda
HMC
$39.1B
| $207K | ﹤0.01% |
6,700
-4,500
| -40% | -$142K |
|
3581
PUT
Axsome Therapeutics
AXSM
$11.2B
| $207K | ﹤0.01% |
2,600
-2,100
| -45% | -$140K |
|
3582
CALL
Dolby
DLB
$5.51B
| $207K | ﹤0.01% |
+2,400
| New | +$202K |
|
3583
Revelation Biosciences
REVB
$3.71M
| $207K | ﹤0.01% |
72
+4
| +6% | +$14.3K |
|
3584
CALL
Twist Bioscience
TWST
$5.7B
| $206K | ﹤0.01% |
5,600
-6,900
| -55% | -$160K |
|
3585
Immunovant
IMVT
$7.93B
| $206K | ﹤0.01% |
4,895
-25,567
| -84% | -$941K |
|
3586
PUT
Oshkosh
OSK
$8.79B
| $206K | ﹤0.01% |
1,900
-35,600
| -95% | -$3.44M |
|
3587
CALL
HealthEquity
HQY
$8.41B
| $206K | ﹤0.01% |
3,100
+2,100
| +210% | +$146K |
|
3588
PUT
Tronox
TROX
$932M
| $205K | ﹤0.01% |
+14,500
| New | +$178K |
|
3589
Hess Midstream
HESM
$5.24B
| $205K | ﹤0.01% |
6,479
-59,104
| -90% | -$1.81M |
|
3590
CALL
Cemex
CX
$17.1B
| $205K | ﹤0.01% |
26,400
| – | – |
|
3591
WSFS Financial
WSFS
$4.12B
| $204K | ﹤0.01% |
+4,448
| New | +$175K |
|
3592
PureCycle Technologies
PCT
$1.28B
| $204K | ﹤0.01% |
50,385
-56,666
| -53% | -$249K |
|
3593
PUT
Domo
DOMO
$174M
| $204K | ﹤0.01% |
+19,800
| New | +$183K |
|
3594
PUT
Kinross Gold
KGC
$27.4B
| $203K | ﹤0.01% |
33,600
+23,900
| +246% | +$131K |
|
3595
CALL
Valley National Bancorp
VLY
$7.9B
| $203K | ﹤0.01% |
18,700
+12,500
| +202% | +$112K |
|
|
ENLC
3596
PUT
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $203K | ﹤0.01% |
16,700
+8,300
| +99% | +$104K |
|
3597
CALL
Eagle Materials
EXP
$6.29B
| $203K | ﹤0.01% |
1,000
+600
| +150% | +$105K |
|
3598
PUT
Endava
DAVA
$158M
| $202K | ﹤0.01% |
2,600
-8,000
| -75% | -$495K |
|
|
ZIMV
3599
DELISTED
ZimVie
ZIMV
| $202K | ﹤0.01% |
+11,396
| New | +$115K |
|
3600
PUT
PubMatic
PUBM
$585M
| $202K | ﹤0.01% |
12,400
+8,600
| +226% | +$125K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Walleye Capital held 5,834 positions worth $47.2B, up 21% from $39.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Walleye Capital deployed $2.33B of net new capital in Q4 2023, opening 1,032 new positions and adding to 1,743 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 2.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $59.4M trimmed.
- Walleye Capital's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.
- Walleye Capital added most to Lam Research in Q4 2023, an estimated $51.4M increase.
- Walleye Capital's biggest Q4 2023 reduction was Advanced Micro Devices, cutting an estimated $59.4M.
- Walleye Capital fully exited VMware, Inc in Q4 2023, selling an estimated $57.2M.
- Walleye Capital's ten largest holdings make up 36% of its $47.2B portfolio in Q4 2023.
- Walleye Capital opened 1,032 new positions and closed 961 in Q4 2023.
- Walleye Capital's portfolio value rose 21% quarter-over-quarter to $47.2B.
Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.